y The regulatory role of sulfated polysaccharides in facilitating rhBMP-2-induced osteogenesis

被引:16
作者
Chen, Han [1 ,2 ]
Yu, Yuanman [1 ,2 ]
Wang, Chenmin [1 ,2 ]
Wang, Jing [1 ,2 ]
Liu, Changsheng [2 ,3 ]
机构
[1] East China Univ Sci & Technol, State Key Lab Bioreactor Engn, Shanghai 200237, Peoples R China
[2] East China Univ Sci & Technol, Minist Educ, Engn Res Ctr Biomed Mat, Shanghai 200237, Peoples R China
[3] East China Univ Sci & Technol, Minist Educ, Key Lab Ultrafine Mat, Shanghai 200237, Peoples R China
基金
中国国家自然科学基金;
关键词
BONE MORPHOGENETIC PROTEIN-2; IN-VITRO; GROWTH-FACTOR; HEPARIN; BMP-2; REGENERATION; SCAFFOLDS; RELEASE; DIFFERENTIATION; BIOACTIVITY;
D O I
10.1039/c9bm00529c
中图分类号
TB3 [工程材料学]; R318.08 [生物材料学];
学科分类号
082905 [生物质能源与材料]; 100103 [病原生物学];
摘要
Sulfated polysaccharides have received much attention in recent years due to their special biological activities, especially the regulation of the biological activity of growth factors such as the representative inductive growth factor recombinant human bone morphogenetic protein-2 (rhBMP-2). However, the regulatory mechanisms from the aspect of the molecular chain structure have rarely been reported. In this article, we selected three kinds of sulfonates containing different backbone structures and functional groups, 2-N,6-O-sulfated chitosan (26 SCS), sulfated dextran (DSS) and poly(sodium-p-styrenesulfonate) (PSS), to explore the interaction between them and rhBMP-2. From in vivo and in vitro osteogenesis-related experiments, 26 SCS showed the best promoting effect on rhBMP-2 induced osteogenic differentiation and the sulfated amino group in 26 SCS could specifically bind to rhBMP-2. These findings indicated that the polysaccharide chain structure was a prerequisite for the synergy effect between 26 SCS and rhBMP-2; the effective combination of -SO3- and rhBMP-2 was an important factor in protecting the bioactivity of rhBMP-2. In addition, the presence of the sulfated amino group was the key factor in the specific binding between 26 SCS and rhBMP-2 and provided the possibility of capturing factors in vivo.
引用
收藏
页码:4375 / 4387
页数:13
相关论文
共 38 条
[1]
Injectable cell-free template for bone-tissue formation [J].
Bergman, Kristoffer ;
Engstrand, Thomas ;
Hilborn, Jons ;
Ossipov, Dmitri ;
Piskounova, Sonya ;
Bowden, Tim .
JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A, 2009, 91A (04) :1111-1118
[2]
Bone morphogenetic proteins in tissue engineering: the road from laboratory to clinic, part II (BMP delivery) [J].
Bessa, P. C. ;
Casal, M. ;
Reis, R. L. .
JOURNAL OF TISSUE ENGINEERING AND REGENERATIVE MEDICINE, 2008, 2 (2-3) :81-96
[3]
MODIFICATION OF LYMPHOCYTE MIGRATION BY SULFATED POLYSACCHARIDES [J].
BRENAN, M ;
PARISH, CR .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1986, 16 (04) :423-430
[4]
Vascularization and bone regeneration in a critical sized defect using 2-N,6-O-sulfated chitosan nanoparticles incorporating BMP-2 [J].
Cao, Lingyan ;
Wang, Jing ;
Hou, Juan ;
Xing, Wanli ;
Liu, Changsheng .
BIOMATERIALS, 2014, 35 (02) :684-698
[5]
Chen F., 2010, ACTA PHARM SIN, V26, P1093
[6]
Enhancement of the biological activity of BMP-2 by synthetic dextran derivatives [J].
Degat, Marie-Christelle ;
Dubreucq, Guy ;
Meunier, Alain ;
Dahri-Correia, Latifa ;
Sedel, Laurent ;
Petite, Herve ;
Logeart-Avramoglou, Delphine .
JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A, 2009, 88A (01) :174-183
[7]
Georges R., 2010, J BONE MINER RES, V18, P1842
[8]
Cross-talk between the bone morphogenetic protein pathway and other major signaling pathways results in tightly regulated cell-specific outcomes [J].
Herpin, Amaury ;
Cunningham, Charles .
FEBS JOURNAL, 2007, 274 (12) :2977-2985
[9]
Effect of local sequential VEGF and BMP-2 delivery on ectopic and orthotopic bone regeneration [J].
Kempen, Diederik H. R. ;
Lu, Lichun ;
Heijink, Andras ;
Hefferan, Theresa E. ;
Creemers, Laura B. ;
Maran, Avudaiappan ;
Yaszemski, Michael J. ;
Dhert, Wouter J. A. .
BIOMATERIALS, 2009, 30 (14) :2816-2825
[10]
Sustained release of vascular endothelial growth factor from calcium-induced alginate hydrogels reinforced by heparin and chitosan [J].
Lee, KW ;
Yoon, JJ ;
Lee, JH ;
Kim, SY ;
Jung, HJ ;
Kim, SJ ;
Joh, JW ;
Lee, HH ;
Lee, DS ;
Lee, SK .
TRANSPLANTATION PROCEEDINGS, 2004, 36 (08) :2464-2465